Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06732453 · ClinicalTrials.gov registry record · NA

Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)

A NA study of Gastroparesis and Functional Dyspepsia, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06732453 is a NA study of Gastroparesis and Functional Dyspepsia that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06732453, a NA study of Gastroparesis and Functional Dyspepsia, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to assess whether using a yoga-based intervention in practice is feasible (possible) and acceptable to patients with Functional Dyspepsia and/or Gastroparesis (FD-GP).

Interventions

  • OTHER Seated Yoga Skills Training in Functional Dyspepsia and Gastroparesis (FD-GP)

Study Locations (1)

North Carolina

  • Atrium Health Gastroenterology and Hepatology Kenilworth - Charlotte

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-06-18
Est. Completion 2026-06
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT06732453

The ClinicalTrials.gov registry entry for NCT06732453 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (97% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Seated Yoga Skills Training in Functional Dyspepsia and Gastroparesis (FD-GP) is the first listed.

NCT06732453 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06732453 about?

NCT06732453 is a clinical study titled "Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)". The purpose of this research study is to assess whether using a yoga-based intervention in practice is feasible (possible) and acceptable to patients with Functional Dyspepsia and/or Gastroparesis (FD-GP).

What is the current status of trial NCT06732453?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-06-18. Estimated completion is 2026-06.

What conditions does trial NCT06732453 study?

This clinical trial studies the following conditions: Gastroparesis, Functional Dyspepsia.

What interventions are being tested in trial NCT06732453?

The interventions under investigation include: Seated Yoga Skills Training in Functional Dyspepsia and Gastroparesis (FD-GP) (OTHER).

Who is sponsoring clinical trial NCT06732453?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06732453 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.